The clinical trial protocol, as a detailed outline of a clinical study, must be rigorously followed by the clinical trial team, not only to be in line with regulations but also to avoid harm to participants and erroneous conclusions. As early-phase trials are becoming increasingly complex, the risk of protocol deviations, necessary amendments, incorrectly gathered data and even inaccurate conclusions may increase.

Please download this free white paper to read more.